NCT01346683

Brief Summary

To investigate the clinical efficacy of OsseoSpeed™ TX implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior mandible up to 3 years after loading. Hypothesis: Early loading of the posterior mandible is a safe and predictable procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 2, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 3, 2011

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

May 10, 2019

Completed
Last Updated

September 27, 2019

Status Verified

September 1, 2019

Enrollment Period

5.1 years

First QC Date

May 2, 2011

Results QC Date

February 11, 2019

Last Update Submit

September 11, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Marginal Bone Level Alteration

    Marginal Bone Level determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal Bone Level expressed in millimeters at the 3 year follow-up visit compared to values obtained at delivery of permanent restoration i.e. loading (baseline).

    Evaluated 3 years after implant loading

Secondary Outcomes (4)

  • Implant Survival

    From implant placement to the follow-up 36 months after loading.

  • Implant Stability

    Measured from loading of implants to the follow-up 36 months after loading.

  • Soft Tissue Status (PPD).

    Measured from loading of implants to the follow-up 36 months after loading.

  • Soft Tissue Status (BoP)

    Measured from loading of implants to the follow-up 36 months after loading.

Study Arms (1)

OsseoSpeed TX

EXPERIMENTAL

OsseoSpeed TX implants of lengths 8-17 mm

Device: OsseoSpeed TX

Interventions

OsseoSpeed TX implants of lengths 8-17 mm

OsseoSpeed TX

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of informed consent
  • Aged 20-75 years at enrolment
  • History of edentulism in the posterior mandible, Kennedy classes I or II, of at least four months. Last natural tooth in function is canine or first bicuspid.
  • Neighboring tooth to the planned bridge must have natural root.
  • Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned bridge.
  • Deemed by the investigator to have adequate bone height and a bone width of minimum 5.5 mm.
  • Deemed by the investigator as likely to present an initially stable implant situation

You may not qualify if:

  • Unlikely to be able to comply with study procedures, as judged by the investigator
  • Earlier graft procedures in the study area
  • Current need for pre-surgical bone or soft tissue augmentation in the planned implant area.
  • Uncontrolled pathologic processes in the oral cavity
  • Known or suspected current malignancy
  • History of radiation therapy in the head and neck region
  • History of chemotherapy within 5 years prior to surgery
  • Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration
  • Uncontrolled diabetes mellitus
  • Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration
  • Smoking more than 10 cigarettes/day
  • Present alcohol and/or drug abuse
  • Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)
  • Previous enrolment in the present study.
  • Simultaneous participation in another clinical study or participation in a clinical study during the last 6 months.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Department of Prosthodontics, School of Stomatology, Beijing University

Beijing, 100081, China

Location

Department of Prosthodontics & Dental Materials, Guanghua School of Stomatology, Sun Yat-Sen University

Guangzhou, 510055, China

Location

Department of Prosthodontics, College of Stomatology, Shanghai Jiao Tong University

Shanghai, 200011, China

Location

Related Publications (1)

  • Zhou J, Huang Q, Wang X, Peng D, Li Y, Zhang L, Liu J, Zhang S, Zhao K, Jiang X, Zhou Y. Early loading of splinted implants in the posterior mandible: a prospective multicentre case series. J Clin Periodontol. 2016 Mar;43(3):298-304. doi: 10.1111/jcpe.12513. Epub 2016 Mar 1.

MeSH Terms

Conditions

Jaw, Edentulous, Partially

Condition Hierarchy (Ancestors)

Jaw, EdentulousJaw DiseasesMusculoskeletal DiseasesStomatognathic DiseasesMouth, EdentulousMouth DiseasesTooth Diseases

Results Point of Contact

Title
Manager Global Clinical Research
Organization
Dentsply Sirona Implants, Mölndal, SWEDEN

Study Officials

  • Yongsheng Zhou, Prof

    Department of Prosthodontics, School of Stomatology, Beijing University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2011

First Posted

May 3, 2011

Study Start

February 1, 2011

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

September 27, 2019

Results First Posted

May 10, 2019

Record last verified: 2019-09

Locations